0001437749-22-002613.txt : 20220207
0001437749-22-002613.hdr.sgml : 20220207
20220207155020
ACCESSION NUMBER: 0001437749-22-002613
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220207
FILED AS OF DATE: 20220207
DATE AS OF CHANGE: 20220207
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FINE N SCOTT
CENTRAL INDEX KEY: 0001163556
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39780
FILM NUMBER: 22597305
MAIL ADDRESS:
STREET 1: 600 3RD AVE
CITY: NEW YORK
STATE: NY
ZIP: 10016
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cyclo Therapeutics, Inc.
CENTRAL INDEX KEY: 0000922247
STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860]
IRS NUMBER: 593029743
STATE OF INCORPORATION: FL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6714 NW 16TH STREET, SUITE B
CITY: GAINESVILLE
STATE: FL
ZIP: 32653
BUSINESS PHONE: 386-418-8060
MAIL ADDRESS:
STREET 1: PO BOX 1180
CITY: ALACHUA
STATE: FL
ZIP: 32616-1180
FORMER COMPANY:
FORMER CONFORMED NAME: CTD HOLDINGS INC
DATE OF NAME CHANGE: 20000913
FORMER COMPANY:
FORMER CONFORMED NAME: CYCLODEXTRIN TECHNOLOGIES DEVELOPMENT INC
DATE OF NAME CHANGE: 19941012
4
1
rdgdoc.xml
FORM 4
X0306
4
2022-02-07
0000922247
Cyclo Therapeutics, Inc.
CYTH
0001163556
FINE N SCOTT
6714 NW 16TH STREET, SUITE B
GAINESVILLE
FL
32163
1
1
Chief Executive Officer
Common Stock
2022-02-07
4
P
0
10334
3.58
A
145000
D
The price reported is a weighted average price. These shares of common stock were purchased in multiple transactions at prices ranging from $3.50 to $3.60, inclusive. The reporting person undertakes to provide to the Issuer and the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price within the foregoing ranges.
/s/ N. Scott Fine
2022-02-07